EFFICACY OF COMMUNITY-BASED PALLIATIVE NURSING MANAGEMENT VERSUS STANDARD HOSPITAL CARE IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS: A SYSTEMATIC REVIEW

Authors

Keywords:

Liver cirrhosis; Palliative care; Nursing; Portal hypertension; Complications; Quality of life; Psychosocial support; Sarcopenia

Abstract

DOI: https://doi.org/10.46296/yc.v10i19.1006

Abstract

Hepatic cirrhosis is a chronic, progressive, and irreversible condition characterized morphophysiologically by the diffuse replacement of functional parenchyma with a dense fibrillar extracellular matrix and abnormally structured regenerative nodules; this drastically alters internal vascular architecture and sinusoidal microcirculation. This structural distortion increases resistance to portal blood flow, triggering clinically significant portal hypertension defined by a hepatic venous pressure gradient exceeding 10 mm Hgwhich acts as the central pathophysiological driver of the most severe clinical manifestations. Epidemiologically, cirrhosis is a leading cause of morbidity and mortality in adults worldwide, driven primarily by sustained harmful alcohol consumption, chronic hepatitis B and C viral infections, and the marked rise in metabolic dysfunction-associated fatty liver disease, alongside less common but complex etiologies such as autoimmune hepatitis, Wilson's disease (copper accumulation), and hereditary hemochromatosis (iron overload). The disease's clinical course progresses from a prolonged, often asymptomatic compensated phase to decompensated stages characterized by the onset of serious complications that drastically compromise short- and medium-term survival. Key decompensation events include ascites, spontaneous bacterial peritonitis resulting from bacterial translocation, gastroesophageal varices carrying a high risk of massive gastrointestinal hemorrhage, hepatic encephalopathy induced by the systemic accumulation of neurotoxins (such as ammonia), hepatorenal syndrome, and eventual progression to hepatocellular carcinoma. In this complex clinical landscape, multidisciplinary and interdisciplinary palliative care stands as an essential component that should not be deferred until the terminal phase but rather integrated early into the patient's ongoing management. Nursing interventions focused on the community and home environment play a pivotal role in alleviating the physical, psychosocial, and spiritual suffering of both the patient and their support network. In the physical realm, nursing care encompasses close hemodynamic monitoring; pharmacological and non-pharmacological management of intractable pain and chronic fatigue; rigorous monitoring of fluid and electrolyte balance; high-protein, high-calorie nutritional support aimed at preventing or counteracting sarcopenia and protein-calorie malnutrition; and the performance of invasive palliative procedures such as the peritoneal drainage of refractory ascites within the community setting. In the psychosocial sphere, nursing fosters the strengthening of family and social support networks, provides ongoing health education for self-care, promotes effective coping mechanisms, and actively prevents caregiver burden or burnout through the equitable redistribution of daily responsibilities. Furthermore, the spiritual dimension is crucial for providing existential comfort, deeply respecting the patient's worldview, rituals, and individual beliefs, while facilitating opportunities for dialogue, reconciliation, and emotional closure. In conclusion, scientific evidence demonstrates that a holistic, humanized, and structured approach by the community nursing team optimizes symptom control, reduces unplanned hospital readmissions, preserves human dignity, and positively transforms the quality of life for patients with advanced liver disease and their families.

Keywords: Liver cirrhosis; Palliative care; Nursing; Portal hypertension; Complications; Quality of life; Psychosocial support; Sarcopenia.

Downloads

Download data is not yet available.

References

World Health Organization. Título del documento [Internet]. Ginebra: WHO; [citado 2025 dic 3]. Disponible en: https://iris.who.int/bitstreams/2843498c-e62d-4c54-8c65-ce5a2027bb60/download

Andrade Villavicencio DA, Coronel Vera JG, López Cartagenova AL, Maldonado Quezada NE, Martínez Santander CJ. Cirrosis, la nueva problemática que afecta a niños y adolescentes. Revis. med. Aneteo [Internet]. 2023 [citado el 25 de octubre de 2025]: 25 (1): 147-162. Disponible en: https://www.colegiomedicosazuay.ec/ojs/index.php/ateneo/article/view/230/229

Vázquez Navarro ME, Templos Esteban LA, García Valdés P. Características clínicas y necesidades paliativas de pacientes con insuficiencia hepática no oncológica atendidos en un servicio de cuidados paliativos. Med.Et [Internet]. 2024 [citado el 24 de octubre de 2025];36(2). 585-610. Disponible en: https://revistas.anahuac.mx/index.php/bioetica/article/view/2828/2839.

Miño Bernal J, Edna López M, Jazmín Sandíno N, Molano Franco M. Cirrosis hepática o falla hepática crónica agudizada: definición y clasificación. Repert. Med. Cir [Internet]. 2022 [citado el 25 de octubre de 2025]: 31 (2): 112-122

Can G, Yuan Y , Haiyuan S, Jinhang G, Xiangxin K, Zhaodi C, Yangkun G, Hua W. Liver diseases: epidemiology, causes, trends and predictions. STTT [Internet]. 2025 [citado el 24 de octubre de 2025]; 10(33): 1-36. Disponible en: file:///Users/usuario/Downloads/s41392-024-02072-z-1.pdf

Juanola A, Posea E y Ginés P. Cirrosis hepática: enfermedad antigua, reto nuevo. Med Clin [Internet]. 2024[citado el 24 de octubre de 2025];164: 238-246 Disponible en: https://www.elsevier.es/es-revista-medicina-clinica-2-pdf-S0025775324007048.

Zavala Hoppe AN, Jaime Palma EN, Ramos Zambrano PL. Cirrosis hepática: prevalencia, causas y diagnóstico de laboratorio. Journal Scientific MQRInvestigar [Internet]. 2024[citado el 24 de octubre de 2025]; 8(1): 2035-2055.https://www.investigarmqr.com/ojs/index.php/mqr/article/view/987/3741.

Danpanichkul P, Díaz LA, Suparan K, Tothanarungro P, Sirimangklanurak P , Auttapracha T, Blaney H , Sukphutanan B, Yaphutananf, Pang Y, Kongarin S, Idalsoaga F. Epidemiología mundial de las enfermedades hepáticas relacionadas con el alcohol, el cáncer de hígado y los trastornos por consumo de alcohol. CMH [Internet]. 2024[citado el 24 de octubre de 2025]; 31: 525-547. Disponible en: https://e-cmh.org/upload/pdf/cmh-2024-0835.pdf.

Solís Alcívar DC, Bermúdez Garcell AJ, Serrano Gámez B, Teruel Ginés R, Castro Maquilón AG. Efectos del alcohol en la aparición de cirrosis hepática. CCM [Internet]. 2020[citado el 24 de octubre de 2025]; 24(2). 761-781 https://www.medigraphic.com/pdfs/correo/ccm2020/ccm202t.pdf?utm_source=chatgpt.com

Peña Ramírez DM, Lizarazo Correa CO, Vargas Rodríguez LJ. Caracterización de la cirrosis hepática en pacientes internados en un hospital universitario de Colombia. Revista, colomb. Gastroenterol [Internet]. 2024[citado el 24 de octubre de 2025]; 40(1):39-45. Disponible en: http://www.scielo.org.co/pdf/rcg/v40n1/es_2500-7440-rcg-40-01-39.pdf .

Calderón Gerstein W, Ascanio Paredes M, Yarinsueca M, Pilar R. Características clínicas y complicaciones de la cirrosis hepática en una población de altura (Huancayo, 3250 m s. n. m.). Horizmed [Internet]. 2020 [citado el 24 de octubre de 2025]; 20(2): 1-8 Disponible en: http://www.scielo.org.pe/pdf/hm/v20n2/1727-558X-hm-20-02-e1186.pdf .

Naik A y Moorthy S. Un análisis comparativo entre la puntuación del Modelo para la Enfermedad Hepática Terminal (MELD), Puntuación del modelo modificado para la enfermedad hepática terminal (MELD Na) y puntuación de Child- Pugh (CPS) para predecir complicaciones en pacientes con cirrosis. The Egyptian Journal of Internal Medicine [Internet]. 2025[citado el 24 de octubre de 2025]; 37(99): 1-10. Disponible en: https://link.springer.com/article/10.1186/s43162-025-00478-x.

World Health Organization. Palliative care [Internet]. Geneva: World Health Organization; 2020 [cited 2025 Oct 24]. Available from: https://www.who.int/es/news-room/fact-sheets/detail/palliative-care who.int.

Sousa L, Marques Silva S, Rego F, Nunes R, Oliveira H. Cuidados paliativos en la enfermedad hepática terminal. Livers [Internet]. 2025 [citado el 11 de Noviemb de 2025]; 5(39): 1–13. Disponible en: https://www.mdpi.com/2673-4389/5/3/39.

Vázquez Navarro ME, Templos Esteban LA, García Valdés P. Características clínicas y necesidades paliativas de pacientes con insuficiencia hepática no oncológica atendidos en un servicio de cuidados paliativos. Med y Ét [Internet]. 2024[citado el 24 de octubre de 2025];36(2):584-635. Disponible en: https://www.scielo.org.mx/pdf/mye/v36n2/2594-2166-mye-36-02-584.pdf.

Juanola A, Pose E, Ginés P. Cirrosis hepática: enfermedad antigua, reto nuevo.Med Clin (Barc) [Internet]. 2025[citado el 21 de nov de 2025];164(5):238-246. https://www.sciencedirect.com/science/article/pii/S0025775324007048?utm_sourc e=chatgpt.com

Published

2026-10-10

How to Cite

Montúfar-Silva, M. R., Guerrero-Rodríguez, J. P., Cujano-Ortiz, J. D., Soto-Ayala, M. P., & Macias-Erazo, A. B. (2026). EFFICACY OF COMMUNITY-BASED PALLIATIVE NURSING MANAGEMENT VERSUS STANDARD HOSPITAL CARE IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS: A SYSTEMATIC REVIEW. REVISTA CIENTÍFICA MULTIDISCIPLINARIA ARBITRADA YACHASUN - ISSN: 2697-3456, 10(19), 1609–1635. Retrieved from https://editorialibkn.com/index.php/Yachasun/article/view/1093